| Type |
Details |
Score |
| GXD Expression |
| Probe: |
MGI:4420592 |
| Assay Type: |
RNA in situ |
| Annotation Date: |
2010-09-14 |
| Strength: |
Weak |
| Sex: |
Not Specified |
| Emaps: |
EMAPS:1625523 |
| Pattern: |
Regionally restricted |
| Stage: |
TS23 |
| Assay Id: |
MGI:4823828 |
| Age: |
embryonic day 14.5 |
| Image: |
euxassay_001440_06 |
|
| Specimen Label: |
euxassay_001440_06 |
| Detected: |
true |
| Specimen Num: |
6 |
|
•
•
•
•
•
|
| GXD Expression |
| Probe: |
MGI:4420592 |
| Assay Type: |
RNA in situ |
| Annotation Date: |
2010-09-14 |
| Strength: |
Weak |
| Sex: |
Not Specified |
| Emaps: |
EMAPS:1625523 |
| Pattern: |
Regionally restricted |
| Stage: |
TS23 |
| Assay Id: |
MGI:4823828 |
| Age: |
embryonic day 14.5 |
| Image: |
euxassay_001440_07 |
|
| Specimen Label: |
euxassay_001440_07 |
| Detected: |
true |
| Specimen Num: |
7 |
|
•
•
•
•
•
|
| GXD Expression |
| Probe: |
MGI:4420592 |
| Assay Type: |
RNA in situ |
| Annotation Date: |
2010-09-14 |
| Strength: |
Weak |
| Sex: |
Not Specified |
| Emaps: |
EMAPS:1625523 |
| Pattern: |
Regionally restricted |
| Stage: |
TS23 |
| Assay Id: |
MGI:4823828 |
| Age: |
embryonic day 14.5 |
| Image: |
euxassay_001440_08 |
|
| Specimen Label: |
euxassay_001440_08 |
| Detected: |
true |
| Specimen Num: |
8 |
|
•
•
•
•
•
|
| GXD Expression |
| Probe: |
MGI:4420592 |
| Assay Type: |
RNA in situ |
| Annotation Date: |
2010-09-14 |
| Strength: |
Weak |
| Sex: |
Not Specified |
| Emaps: |
EMAPS:1625523 |
| Pattern: |
Regionally restricted |
| Stage: |
TS23 |
| Assay Id: |
MGI:4823828 |
| Age: |
embryonic day 14.5 |
| Image: |
euxassay_001440_09 |
|
| Specimen Label: |
euxassay_001440_09 |
| Detected: |
true |
| Specimen Num: |
9 |
|
•
•
•
•
•
|
| GXD Expression |
| Probe: |
MGI:4420592 |
| Assay Type: |
RNA in situ |
| Annotation Date: |
2010-09-14 |
| Strength: |
Weak |
| Sex: |
Not Specified |
| Emaps: |
EMAPS:1625523 |
| Pattern: |
Regionally restricted |
| Stage: |
TS23 |
| Assay Id: |
MGI:4823828 |
| Age: |
embryonic day 14.5 |
| Image: |
euxassay_001440_10 |
|
| Specimen Label: |
euxassay_001440_10 |
| Detected: |
true |
| Specimen Num: |
10 |
|
•
•
•
•
•
|
| GXD Expression |
| Probe: |
MGI:4420592 |
| Assay Type: |
RNA in situ |
| Annotation Date: |
2010-09-14 |
| Strength: |
Weak |
| Sex: |
Not Specified |
| Emaps: |
EMAPS:1625523 |
| Pattern: |
Regionally restricted |
| Stage: |
TS23 |
| Assay Id: |
MGI:4823828 |
| Age: |
embryonic day 14.5 |
| Image: |
euxassay_001440_11 |
|
| Specimen Label: |
euxassay_001440_11 |
| Detected: |
true |
| Specimen Num: |
11 |
|
•
•
•
•
•
|
| GXD Expression |
| Probe: |
MGI:4420592 |
| Assay Type: |
RNA in situ |
| Annotation Date: |
2010-09-14 |
| Strength: |
Weak |
| Sex: |
Not Specified |
| Emaps: |
EMAPS:1625523 |
| Pattern: |
Regionally restricted |
| Stage: |
TS23 |
| Assay Id: |
MGI:4823828 |
| Age: |
embryonic day 14.5 |
| Image: |
euxassay_001440_12 |
|
| Specimen Label: |
euxassay_001440_12 |
| Detected: |
true |
| Specimen Num: |
12 |
|
•
•
•
•
•
|
| GXD Expression |
| Probe: |
MGI:4420592 |
| Assay Type: |
RNA in situ |
| Annotation Date: |
2010-09-14 |
| Strength: |
Weak |
| Sex: |
Not Specified |
| Emaps: |
EMAPS:1625523 |
| Pattern: |
Regionally restricted |
| Stage: |
TS23 |
| Assay Id: |
MGI:4823828 |
| Age: |
embryonic day 14.5 |
| Image: |
euxassay_001440_13 |
|
| Specimen Label: |
euxassay_001440_13 |
| Detected: |
true |
| Specimen Num: |
13 |
|
•
•
•
•
•
|
| GXD Expression |
| Probe: |
MGI:4420592 |
| Assay Type: |
RNA in situ |
| Annotation Date: |
2010-09-14 |
| Strength: |
Weak |
| Sex: |
Not Specified |
| Emaps: |
EMAPS:1625523 |
| Pattern: |
Regionally restricted |
| Stage: |
TS23 |
| Assay Id: |
MGI:4823828 |
| Age: |
embryonic day 14.5 |
| Image: |
euxassay_001440_14 |
|
| Specimen Label: |
euxassay_001440_14 |
| Detected: |
true |
| Specimen Num: |
14 |
|
•
•
•
•
•
|
| GXD Expression |
| Probe: |
MGI:4420592 |
| Assay Type: |
RNA in situ |
| Annotation Date: |
2010-09-14 |
| Strength: |
Moderate |
| Sex: |
Not Specified |
| Emaps: |
EMAPS:1625523 |
| Pattern: |
Regionally restricted |
| Stage: |
TS23 |
| Assay Id: |
MGI:4823828 |
| Age: |
embryonic day 14.5 |
| Image: |
euxassay_001440_15 |
|
| Specimen Label: |
euxassay_001440_15 |
| Detected: |
true |
| Specimen Num: |
15 |
|
•
•
•
•
•
|
| GXD Expression |
| Probe: |
MGI:4420592 |
| Assay Type: |
RNA in situ |
| Annotation Date: |
2010-09-14 |
| Strength: |
Moderate |
| Sex: |
Not Specified |
| Emaps: |
EMAPS:1625523 |
| Pattern: |
Regionally restricted |
| Stage: |
TS23 |
| Assay Id: |
MGI:4823828 |
| Age: |
embryonic day 14.5 |
| Image: |
euxassay_001440_16 |
|
| Specimen Label: |
euxassay_001440_16 |
| Detected: |
true |
| Specimen Num: |
16 |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
coisogenic, mutant strain, endonuclease-mediated mutation |
|
•
•
•
•
•
|
| Allele |
| Name: |
CASP8 and FADD-like apoptosis regulator; targeted mutation 1, Tak W Mak |
| Allele Type: |
Targeted |
| Attribute String: |
Null/knockout |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
congenic, mutant strain, targeted mutation |
|
•
•
•
•
•
|
| Allele |
| Name: |
CASP8 and FADD-like apoptosis regulator; targeted mutation 1a, Wellcome Trust Sanger Institute |
| Allele Type: |
Targeted |
| Attribute String: |
Conditional ready, Null/knockout, Reporter |
|
•
•
•
•
•
|
| Allele |
| Name: |
CASP8 and FADD-like apoptosis regulator; targeted mutation 1e, Wellcome Trust Sanger Institute |
| Allele Type: |
Targeted |
| Attribute String: |
Null/knockout, Reporter |
|
•
•
•
•
•
|
| Allele |
| Name: |
CASP8 and FADD-like apoptosis regulator; targeted mutation 1.1, Richard M Pope |
| Allele Type: |
Targeted |
| Attribute String: |
Conditional ready, No functional change |
|
•
•
•
•
•
|
| Allele |
| Name: |
CASP8 and FADD-like apoptosis regulator; targeted mutation 1.2, Richard M Pope |
| Allele Type: |
Targeted |
| Attribute String: |
Null/knockout |
|
•
•
•
•
•
|
| Allele |
| Name: |
CASP8 and FADD-like apoptosis regulator; targeted mutation 1b, Wellcome Trust Sanger Institute |
| Allele Type: |
Targeted |
| Attribute String: |
Null/knockout, Reporter |
|
•
•
•
•
•
|
| Allele |
| Name: |
CASP8 and FADD-like apoptosis regulator; endonuclease-mediated mutation 1, GemPharmatech Co., Ltd |
| Allele Type: |
Endonuclease-mediated |
| Attribute String: |
Conditional ready, No functional change |
|
•
•
•
•
•
|
| Allele |
| Name: |
CASP8 and FADD-like apoptosis regulator; endonuclease-mediated mutation 5, GemPharmatech Co., Ltd |
| Allele Type: |
Endonuclease-mediated |
| Attribute String: |
Null/knockout |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Wittkopf N |
| Year: |
2013 |
| Journal: |
Gastroenterology |
| Title: |
Cellular FLICE-like inhibitory protein secures intestinal epithelial cell survival and immune homeostasis by regulating caspase-8. |
| Volume: |
145 |
| Issue: |
6 |
| Pages: |
1369-79 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Lin YC |
| Year: |
2010 |
| Journal: |
Toxicol Sci |
| Title: |
FasL gene-deficient mice display a limited disruption in spermatogenesis and inhibition of mono-(2-ethylhexyl) phthalate-induced germ cell apoptosis. |
| Volume: |
114 |
| Issue: |
2 |
| Pages: |
335-45 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Yu Y |
| Year: |
2009 |
| Journal: |
Blood |
| Title: |
Abundant c-Fas-associated death domain-like interleukin-1-converting enzyme inhibitory protein expression determines resistance of T helper 17 cells to activation-induced cell death. |
| Volume: |
114 |
| Issue: |
5 |
| Pages: |
1026-8 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Zhu JY |
| Year: |
2009 |
| Journal: |
Cell Death Differ |
| Title: |
Rocaglamide sensitizes leukemic T cells to activation-induced cell death by differential regulation of CD95L and c-FLIP expression. |
| Volume: |
16 |
| Issue: |
9 |
| Pages: |
1289-99 |
|
•
•
•
•
•
|
| Allele |
| Name: |
caspase 8; endonuclease-mediated mutation 1, Shanghai Model Organisms Center |
| Allele Type: |
Endonuclease-mediated |
| Attribute String: |
Conditional ready, No functional change |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
mutant strain, coisogenic, targeted mutation |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
coisogenic, targeted mutation |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Cflar/Cflar |
| Background: |
either: (involves: 129P2/OlaHsd * C57BL/6J) or (involves: 129P2/OlaHsd * CD-1) |
| Zygosity: |
hm |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Cflar/Cflar Tg(Lck-cre)548Jxm/? |
| Background: |
involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6 * CBA |
| Zygosity: |
cn |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Cflar/Cflar |
| Background: |
C57BL/6N-Cflar/Orl |
| Zygosity: |
hm |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Huo J |
| Year: |
2009 |
| Journal: |
Cell Death Differ |
| Title: |
Genetic deletion of faim reveals its role in modulating c-FLIP expression during CD95-mediated apoptosis of lymphocytes and hepatocytes. |
| Volume: |
16 |
| Issue: |
7 |
| Pages: |
1062-70 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Llobet D |
| Year: |
2011 |
| Journal: |
Am J Pathol |
| Title: |
KSR1 is overexpressed in endometrial carcinoma and regulates proliferation and TRAIL-induced apoptosis by modulating FLIP levels. |
| Volume: |
178 |
| Issue: |
4 |
| Pages: |
1529-43 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Haverkamp JM |
| Year: |
2014 |
| Journal: |
Immunity |
| Title: |
Myeloid-derived suppressor activity is mediated by monocytic lineages maintained by continuous inhibition of extrinsic and intrinsic death pathways. |
| Volume: |
41 |
| Issue: |
6 |
| Pages: |
947-59 |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Cflar/Cflar<+> |
| Background: |
C57BL/6N-Cflar/Orl |
| Zygosity: |
ht |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Bank U |
| Year: |
2020 |
| Journal: |
Nat Commun |
| Title: |
c-FLIP is crucial for IL-7/IL-15-dependent NKp46+ ILC development and protection from intestinal inflammation in mice. |
| Volume: |
11 |
| Issue: |
1 |
| Pages: |
1056 |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
coisogenic, mutant strain, endonuclease-mediated mutation |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Maudet C |
| Year: |
2022 |
| Journal: |
Nature |
| Title: |
Bacterial inhibition of Fas-mediated killing promotes neuroinvasion and persistence. |
| Volume: |
603 |
| Issue: |
7903 |
| Pages: |
900-906 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Chastagner P |
| Year: |
2002 |
| Journal: |
J Immunol |
| Title: |
Lymphoadenopathy in IL-2-deficient mice: further characterization and overexpression of the antiapoptotic molecule cellular FLIP. |
| Volume: |
169 |
| Issue: |
7 |
| Pages: |
3644-51 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Taoufik E |
| Year: |
2007 |
| Journal: |
J Neurosci |
| Title: |
FLIP(L) protects neurons against in vivo ischemia and in vitro glucose deprivation-induced cell death. |
| Volume: |
27 |
| Issue: |
25 |
| Pages: |
6633-46 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Ye J |
| Year: |
2013 |
| Journal: |
J Cell Sci |
| Title: |
A pathway involving HDAC5, cFLIP and caspases regulates expression of the splicing regulator polypyrimidine tract binding protein in the heart. |
| Volume: |
126 |
| Issue: |
Pt 7 |
| Pages: |
1682-91 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Tao RH |
| Year: |
2011 |
| Journal: |
Blood |
| Title: |
PMLRARα binds to Fas and suppresses Fas-mediated apoptosis through recruiting c-FLIP in vivo. |
| Volume: |
118 |
| Issue: |
11 |
| Pages: |
3107-18 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Vesely ED |
| Year: |
2009 |
| Journal: |
Am J Physiol Cell Physiol |
| Title: |
GLUT1-induced cFLIP expression promotes proliferation and prevents apoptosis in vascular smooth muscle cells. |
| Volume: |
297 |
| Issue: |
3 |
| Pages: |
C759-65 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Gilbert S |
| Year: |
2004 |
| Journal: |
Mol Cell Biol |
| Title: |
Keratins modulate c-Flip/extracellular signal-regulated kinase 1 and 2 antiapoptotic signaling in simple epithelial cells. |
| Volume: |
24 |
| Issue: |
16 |
| Pages: |
7072-81 |
|
•
•
•
•
•
|
| Allele |
| Name: |
transgene insertion, David Wallach |
| Allele Type: |
Transgenic |
| Attribute String: |
Conditional ready, Epitope tag, Inserted expressed sequence, Reporter |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Cflar/Cflar Lyz2/Lyz2<+> |
| Background: |
involves: 129P2/OlaHsd |
| Zygosity: |
cn |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Cflar/Cflar Gt(ROSA)26Sor/Gt(ROSA)26Sor<+> Ripk3/Ripk3 |
| Background: |
involves: 129S6/SvEvTac * C57BL/6N * C57BL/6NTac |
| Zygosity: |
cn |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Protein Coding Gene |
| Type: |
protein_coding_gene |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Protein Coding Gene |
| Type: |
protein_coding_gene |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Protein Coding Gene |
| Type: |
protein_coding_gene |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Protein Coding Gene |
| Type: |
protein_coding_gene |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Protein Coding Gene |
| Type: |
protein_coding_gene |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
310
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
327
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
279
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
381
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
291
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Behnke JM |
| Year: |
2006 |
| Journal: |
Mamm Genome |
| Title: |
High resolution mapping of chromosomal regions controlling resistance to gastrointestinal nematode infections in an advanced intercross line of mice. |
| Volume: |
17 |
| Issue: |
6 |
| Pages: |
584-97 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Elzey BD |
| Year: |
2001 |
| Journal: |
J Immunol |
| Title: |
Regulation of Fas ligand-induced apoptosis by TNF. |
| Volume: |
167 |
| Issue: |
6 |
| Pages: |
3049-56 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Moubarak RS |
| Year: |
2010 |
| Journal: |
J Neurosci |
| Title: |
The death receptor antagonist FLIP-L interacts with Trk and is necessary for neurite outgrowth induced by neurotrophins. |
| Volume: |
30 |
| Issue: |
17 |
| Pages: |
6094-105 |
|
•
•
•
•
•
|
| Allele |
| Name: |
transgene insertion 1, Martin Zoernig |
| Allele Type: |
Transgenic |
| Attribute String: |
Inserted expressed sequence |
|
•
•
•
•
•
|
| Allele |
| Name: |
transgene insertion, David Wallach |
| Allele Type: |
Transgenic |
| Attribute String: |
Conditional ready, Epitope tag, Inserted expressed sequence, Reporter |
|
•
•
•
•
•
|
| HT Experiment |
|
| Experiment Type: |
RNA-Seq |
| Study Type: |
WT vs. Mutant |
| Source: |
GEO |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
congenic, mutant strain, transgenic |
|
•
•
•
•
•
|
| Protein Coding Gene |
| Type: |
protein_coding_gene |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
205
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Li H |
| Year: |
1998 |
| Journal: |
Cell |
| Title: |
Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. |
| Volume: |
94 |
| Issue: |
4 |
| Pages: |
491-501 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Urresti J |
| Year: |
2016 |
| Journal: |
J Biol Chem |
| Title: |
Lifeguard Inhibits Fas Ligand-mediated Endoplasmic Reticulum-Calcium Release Mandatory for Apoptosis in Type II Apoptotic Cells. |
| Volume: |
291 |
| Issue: |
3 |
| Pages: |
1221-34 |
|
•
•
•
•
•
|
| Protein Coding Gene |
| Type: |
protein_coding_gene |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
656
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
480
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Najafov A |
| Year: |
2021 |
| Journal: |
Mol Cell |
| Title: |
RIPK1 Promotes Energy Sensing by the mTORC1 Pathway. |
| Volume: |
81 |
| Issue: |
2 |
| Pages: |
370-385.e7 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Supper E |
| Year: |
2021 |
| Journal: |
Nat Commun |
| Title: |
Cut-like homeobox 1 (CUX1) tumor suppressor gene haploinsufficiency induces apoptosis evasion to sustain myeloid leukemia. |
| Volume: |
12 |
| Issue: |
1 |
| Pages: |
2482 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Fiory F |
| Year: |
2009 |
| Journal: |
Am J Physiol Endocrinol Metab |
| Title: |
Frontiers: PED/PEA-15, a multifunctional protein controlling cell survival and glucose metabolism. |
| Volume: |
297 |
| Issue: |
3 |
| Pages: |
E592-601 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Nagarajan A |
| Year: |
2014 |
| Journal: |
Mol Cell Biol |
| Title: |
PEA15 regulates the DNA damage-induced cell cycle checkpoint and oncogene-directed transformation. |
| Volume: |
34 |
| Issue: |
12 |
| Pages: |
2264-82 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Condorelli G |
| Year: |
1999 |
| Journal: |
Oncogene |
| Title: |
PED/PEA-15: an anti-apoptotic molecule that regulates FAS/TNFR1-induced apoptosis. |
| Volume: |
18 |
| Issue: |
31 |
| Pages: |
4409-15 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Viparelli F |
| Year: |
2008 |
| Journal: |
J Biol Chem |
| Title: |
Targeting of PED/PEA-15 molecular interaction with phospholipase D1 enhances insulin sensitivity in skeletal muscle cells. |
| Volume: |
283 |
| Issue: |
31 |
| Pages: |
21769-78 |
|
•
•
•
•
•
|
| Protein Domain |
| Type: |
Domain |
| Description: |
Astrocytic phosphoprotein PEA-15 is a multifunctional protein that is involved in different biological processes and regulates several signalling pathways []. It contains N-terminal death effector domain (DED) and a C-terminal tail with irregular structure []. Expression of PEA-15 oscillates throughout the cell cycle, and the loss of PEA15 accelerates cell cycle progression []. PEA-15 blocks Ras-mediated inhibition of integrin activation and modulates the ERK MAP kinase cascade []. It inhibits both TNFRSF6- and TNFRSF1A-mediated CASP8 activity and apoptosis []. It also functions as a tumour suppressor by triggering the DNA damage-induced G2/M checkpoint and inhibiting RAS-mediated transformation []. In humans PEA-15 is regarded as an important target for type 2 diabetes. PEA-15 overexpression impairs insulin regulation of glucose transport, and this is mediated by its interaction with the C-terminal D4 domain of phospholipase D1 (PLD1) and the consequent increase of protein kinase C-alpha activity []. This entry represents the Death Effector Domain (DED) of PEA15. |
|
•
•
•
•
•
|
| Protein Coding Gene |
| Type: |
protein_coding_gene |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
501
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Magarin M |
| Year: |
2016 |
| Journal: |
J Mol Cell Cardiol |
| Title: |
Embryonic cardiomyocytes can orchestrate various cell protective mechanisms to survive mitochondrial stress. |
| Volume: |
97 |
|
| Pages: |
1-14 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Lamhamedi-Cherradi SE |
| Year: |
2001 |
| Journal: |
Diabetes |
| Title: |
Further mapping of the Idd5.1 locus for autoimmune diabetes in NOD mice. |
| Volume: |
50 |
| Issue: |
12 |
| Pages: |
2874-8 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Lu JV |
| Year: |
2011 |
| Journal: |
Proc Natl Acad Sci U S A |
| Title: |
Complementary roles of Fas-associated death domain (FADD) and receptor interacting protein kinase-3 (RIPK3) in T-cell homeostasis and antiviral immunity. |
| Volume: |
108 |
| Issue: |
37 |
| Pages: |
15312-7 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Bernabé-Rubio M |
| Year: |
2024 |
| Journal: |
Proc Natl Acad Sci U S A |
| Title: |
Caspase-8-dependent autophagy regulates neutrophil infiltration in oral squamous cell carcinoma. |
| Volume: |
121 |
| Issue: |
50 |
| Pages: |
e2406944121 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Zhang Z |
| Year: |
2021 |
| Journal: |
FASEB J |
| Title: |
CDKN2A deregulation in fatty liver disease and its accelerative role in the process of lipogenesis. |
| Volume: |
35 |
| Issue: |
4 |
| Pages: |
e21230 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Hägglöf T |
| Year: |
2023 |
| Journal: |
Front Immunol |
| Title: |
RIPK1 deficiency prevents thymic NK1.1 expression and subsequent iNKT cell development. |
| Volume: |
14 |
|
| Pages: |
1103591 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Shindo R |
| Year: |
2019 |
| Journal: |
iScience |
| Title: |
Necroptosis of Intestinal Epithelial Cells Induces Type 3 Innate Lymphoid Cell-Dependent Lethal Ileitis. |
| Volume: |
15 |
|
| Pages: |
536-551 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Niu C |
| Year: |
2019 |
| Journal: |
Autophagy |
| Title: |
Metformin alleviates hyperglycemia-induced endothelial impairment by downregulating autophagy via the Hedgehog pathway. |
| Volume: |
15 |
| Issue: |
5 |
| Pages: |
843-870 |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
130
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
127
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
92
 |
| Fragment?: |
true |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Scaffidi C |
| Year: |
1999 |
| Journal: |
J Biol Chem |
| Title: |
The role of c-FLIP in modulation of CD95-induced apoptosis. |
| Volume: |
274 |
| Issue: |
3 |
| Pages: |
1541-8 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Budd RC |
| Year: |
2006 |
| Journal: |
Nat Rev Immunol |
| Title: |
cFLIP regulation of lymphocyte activation and development. |
| Volume: |
6 |
| Issue: |
3 |
| Pages: |
196-204 |
|
•
•
•
•
•
|
| Protein Domain |
| Type: |
Family |
| Description: |
This group of sequences represent the p45 (45kDa) precursor of caspases, which can be processed to produce the active p20 (20kDa) and p10 (10kDa) subunits. Caspases (Cysteine-dependent ASPartyl-specific proteASE) are cysteine peptidases that belong to the MEROPS peptidase family C14 (caspase family, clan CD) based on the architecture of their catalytic dyad or triad []. Caspases are tightly regulated proteins that require zymogen activation to become active, and once active can be regulated by caspase inhibitors. Activated caspases act as cysteine proteases, using the sulphydryl group of a cysteine side chain for catalysing peptide bond cleavage at aspartyl residues in their substrates. The catalytic cysteine and histidine residues are on the p20 subunit after cleavage of the p45 precursor.Caspases are mainly involved in mediating cell death (apoptosis) [, , ]. They have two main roles within the apoptosis cascade: as initiators that trigger the cell death process, and as effectors of the process itself. Caspase-mediated apoptosis follows two main pathways, one extrinsic and the other intrinsic or mitochondrial-mediated. The extrinsic pathway involves the stimulation of various TNF (tumour necrosis factor) cell surface receptors on cells targeted to die by various TNF cytokines that are produced by cells such as cytotoxic T cells. The activated receptor transmits the signal to the cytoplasm by recruiting FADD, which forms a death-inducing signalling complex (DISC) with caspase-8. The subsequent activation of caspase-8 initiates the apoptosis cascade involving caspases 3, 4, 6, 7, 9 and 10. The intrinsic pathway arises from signals that originate within the cell as a consequence of cellular stress or DNA damage. The stimulation or inhibition of different Bcl-2 family receptors results in the leakage of cytochrome c from the mitochondria, and the formation of an apoptosome composed of cytochrome c, Apaf1 and caspase-9. The subsequent activation of caspase-9 initiates the apoptosis cascade involving caspases 3 and 7, among others. At the end of the cascade, caspases act on a variety of signal transduction proteins, cytoskeletal and nuclear proteins, chromatin-modifying proteins, DNA repair proteins and endonucleases that destroy the cell by disintegrating its contents, including its DNA. The different caspases have different domain architectures depending upon where they fit into the apoptosis cascades, however they all carry the catalytic p10 and p20 subunits.Caspases can have roles other than in apoptosis, such as caspase-1 (interleukin-1 beta convertase) (), which is involved in the inflammatory process. The activation of apoptosis can sometimes lead to caspase-1 activation, providing a link between apoptosis and inflammation, such as during the targeting of infected cells. Caspases may also be involved in cell differentiation [].There are non-peptidase homologues in the caspase family, such as CASP8 and FADD-like apoptosis regulator (CASH/c-FLIP), which suppresses death receptor induced apoptosis and TCR activation induced cell death by inhibiting caspase-8 activation [, , ]. |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
176
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
93
 |
| Fragment?: |
true |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Archambaud C |
| Year: |
2012 |
| Journal: |
Proc Natl Acad Sci U S A |
| Title: |
Impact of lactobacilli on orally acquired listeriosis. |
| Volume: |
109 |
| Issue: |
41 |
| Pages: |
16684-9 |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
193
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
193
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
151
 |
| Fragment?: |
true |
|
•
•
•
•
•
|